Clinical Trial Update: Efficacy and Safety of HCP1102 Capsule [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of HCP1102 Capsule for asthma with allergic rhinitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Drugs mentioned

• HCP1102 Capsule

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Asthma With Allergic Rhinitis | Phase 3 | Status: COMPLETED